ArticlePlacenta2026
Exposure to oligomeric and fibrillar species of amyloid-β induces toxicity and impairs extravillous trophoblast cell function in vitro.
Article in Placenta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMisfolding of proteins and their subsequent assembly into supramolecular aggregates are key pathophysiological mechanisms involved in neurodegenerative diseases, such as Alzheimer's disease (AD). These aggregates range from small prefibrillar oligomers to large fibrils of β-sheet-rich assemblies that can accumulate in tissues and disrupt normal physiological function. In AD, accumulation of amyloid-β (Aβ) oligomers (AβO) and fibrils (AβF) in the brain is a hallmark of disease. Critically, Aβ aggregates, among other proteins, are also detectable in the serum, urine, and placenta of women with preeclampsia (PE). However, the effects of misfolded protein buildup on placental function remain unclear. We hypothesized that accumulation of Aβ aggregates in placental tissue may disrupt key cellular processes, notably, extravillous trophoblast (EVT) cell survival, migration, and invasion.
methodsHTR-8/SVneo cells, an immortalized EVT cell line, were exposed to exogenous AβO or AβF preparations. Cytotoxicity, cell death mechanism, cell migration, and cell invasion were assessed using MTT, apoptosis/necrosis assays, scratch assays, and Transwell invasion assays, respectively.
resultsWhile both AβO and AβF induced cytotoxicity via apoptosis in EVT cells, AβO had a more profound effect than AβF (p < 0.001). Furthermore, scratch assays revealed that AβO decreased the rate of cell migration while AβF led to an increased rate compared to vehicle controls. Finally, both AβO and AβF inhibited epidermal growth factor-mediated cellular invasion when tested in a Transwell assay (p = 0.017). DISCUSSION: Our findings indicate that exposure to aggregated Aβ species alters trophoblast function in vitro in ways that may be relevant to placental mechanisms associated with preeclampsia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.